Constitutive CD40 Signaling in Dendritic Cells Limits Atherosclerosis by Provoking Inflammatory Bowel Disease and Ensuing Cholesterol Malabsorption

Pascal Kusters, Tom Seijkens, Christina Buerger, Bart Legein, Holger Winkels, Marion Gijbels, Christian Barthels, Remy Bennett, Linda Beckers, Dorothee Atzler, Erik Biessen, Thomas Brocker, Christian Weber, Norbert Gerdes, Esther Lutgenst*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2912-2919
Number of pages8
JournalAmerican Journal of Pathology
Volume187
Issue number12
DOIs
Publication statusPublished - Dec 2017

Keywords

  • B-CELLS
  • CROHNS-DISEASE
  • EXPERIMENTAL COLITIS
  • MICE
  • INHIBITION
  • IMMUNITY
  • HOMEOSTASIS
  • MECHANISMS
  • PHENOTYPE
  • PATHWAY

Cite this

Kusters, P., Seijkens, T., Buerger, C., Legein, B., Winkels, H., Gijbels, M., Barthels, C., Bennett, R., Beckers, L., Atzler, D., Biessen, E., Brocker, T., Weber, C., Gerdes, N., & Lutgenst, E. (2017). Constitutive CD40 Signaling in Dendritic Cells Limits Atherosclerosis by Provoking Inflammatory Bowel Disease and Ensuing Cholesterol Malabsorption. American Journal of Pathology, 187(12), 2912-2919. https://doi.org/10.1016/j.ajpath.2017.08.016